Fundamental mechanisms causing pituitary stem cell aging in mice and humans
导致小鼠和人类垂体干细胞衰老的基本机制
基本信息
- 批准号:10947303
- 负责人:
- 金额:$ 5.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-21 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Project Summary
The pituitary gland produces hormones which maintain homeostasis of multiple target organs over the course
of adult life, yet pituitary cells gradually display signs of reduced cellular and biological activity as animals age.
Pituitary growth hormone production naturally declines with age in a process called the somatopause and is
very low in humans over 60 years old. Adult pituitary stem cells expressing the stem marker SOX2 comprise a
small proportion of adult pituitary cells and can proliferate and differentiate to regenerate nascent endocrine
cells after organ damage or in response to physiologic demands. The number of pituitary stem cells declines
over the course of adult life, and their ability to regenerate in response to organ damage rapidly declines with
age, becoming very limited as early as middle-age at 8-months in mice. The fundamental mechanisms
responsible for age-related loss of pituitary stem cell regenerative capacity are virtually unexplored. In this
proposal, we will utilize cutting edge genomic and in vitro technologies to elucidate pituitary stem cell gene
expression patterns over the course of aging and functionally determine which genes are required for pituitary
stem cell-mediated regeneration. First, we will combine fluorescence activated cell sorting with single-cell RNA
sequencing in order to build a sex-specific single-cell atlas of mouse pituitary stem cell transcriptomics
between the ages of 2-month-old regenerative stem cells through to 8-month-old non-regenerative stem cells.
This novel data will unveil the dynamic temporal changes in gene regulatory networks governing pituitary stem
cell behavior throughout life and identify novel candidate genes causing loss of regeneration in old pituitary
stem cells. Second, we will functionally validate the role of novel genes in pituitary stem cell proliferation and
differentiation identified from our preliminary data and single-cell atlas. We will utilize an established small
interfering knockdown assay to inhibit expression of the two candidates from our preliminary data that are
young-stem cell specific for their ability to promote stem cell proliferation and/or differentiation. We will
concurrently engineer a novel pituitary-specific fluorescent reporter gene in a human induced pluripotent stem
cell line. This indicator of pituitary commitment in organoids will facilitate transitioning future functional studies
of pituitary stem cell aging to a human in vitro model. Using these approaches, we will generate hypotheses
and test candidate genes for regulation of age-dependent pituitary stem cell regeneration. This will uncover
the molecular mechanisms enabling postnatal pituitary stem cell proliferation and differentiation. In the long
term, this knowledge will aid efforts to prolong regeneration and combat aging of pituitary cells in the elderly.
项目摘要
脑下垂体产生激素,在整个过程中维持多个靶器官的体内平衡
然而,随着动物年龄的增长,垂体细胞逐渐显示出细胞和生物活性降低的迹象。
垂体生长激素的产生随着年龄的增长而自然下降,这一过程被称为体细胞周期,
在60岁以上的人群中非常低。表达干细胞标志物SOX 2的成体垂体干细胞包含一个表达干细胞标志物SOX 2的细胞。
小比例的成体垂体细胞,可增殖和分化以再生新生的内分泌
器官损伤后的细胞或对生理需求的反应。垂体干细胞数量下降
随着年龄的增长,它们对器官损伤的再生能力迅速下降,
年龄,在小鼠中早在8个月的中年时就变得非常有限。的基本机制
与年龄相关的垂体干细胞再生能力丧失的原因实际上还未被探索。在这
我们将利用最先进的基因组和体外技术来阐明垂体干细胞基因
在衰老过程中的表达模式和功能决定了哪些基因是垂体
干细胞介导再生首先,我们将联合收割机荧光激活细胞分选与单细胞RNA
测序,以建立小鼠垂体干细胞转录组学的性别特异性单细胞图谱
从2个月大的再生干细胞到8个月大的非再生干细胞。
这一新的数据将揭示垂体干基因调控网络的动态时间变化
细胞行为,并确定新的候选基因造成的损失再生旧垂体
干细胞其次,我们将在功能上验证新基因在垂体干细胞增殖中的作用,
从我们的初步数据和单细胞图谱中鉴定出的分化。我们将利用现有的小型
干扰敲低测定以抑制来自我们的初步数据的两种候选物的表达,
干细胞-对它们促进干细胞增殖和/或分化的能力特异的干细胞。我们将
在人诱导多能干细胞中同时工程化新垂体特异性荧光报告基因
细胞系这一垂体在类器官中的承诺指标将促进未来功能研究的过渡
垂体干细胞衰老的体外模型。使用这些方法,我们将生成假设
并测试调节年龄依赖性垂体干细胞再生的候选基因。这将揭开
促进垂体干细胞增殖和分化的分子机制。从长远
从长远来看,这些知识将有助于延长老年人垂体细胞的再生和对抗衰老。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Leonard Yan Ming Cheung其他文献
Leonard Yan Ming Cheung的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Leonard Yan Ming Cheung', 18)}}的其他基金
Fundamental Mechanisms Causing Pituitary Stem Cell Aging in Mice and Humans
导致小鼠和人类垂体干细胞衰老的基本机制
- 批准号:
10369324 - 财政年份:2022
- 资助金额:
$ 5.81万 - 项目类别:
Fundamental Mechanisms Causing Pituitary Stem Cell Aging in Mice and Humans
导致小鼠和人类垂体干细胞衰老的基本机制
- 批准号:
10627790 - 财政年份:2022
- 资助金额:
$ 5.81万 - 项目类别:
相似国自然基金
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
- 批准号:
- 批准年份:2024
- 资助金额:万元
- 项目类别:外国学者研究基金
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
- 批准号:W2433169
- 批准年份:2024
- 资助金额:万元
- 项目类别:外国学者研究基金项目
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
- 批准号:82371255
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
- 批准号:82370979
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
- 批准号:82370981
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
Idh3a作为线粒体代谢—表观遗传检查点调控产热脂肪功能的机制研究
- 批准号:82370851
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
用于小尺寸管道高分辨成像荧光聚合物点的构建、成像机制及应用研究
- 批准号:82372015
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
小脑浦肯野细胞突触异常在特发性震颤中的作用机制及靶向干预研究
- 批准号:82371248
- 批准年份:2023
- 资助金额:47.00 万元
- 项目类别:面上项目
声致离子电流促进小胶质细胞M2极化阻断再生神经瘢痕退变免疫机制
- 批准号:82371973
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
- 批准号:82371652
- 批准年份:2023
- 资助金额:45.00 万元
- 项目类别:面上项目
相似海外基金
Elucidation of the molecular mechanisms driving the co-evolution between red tide-causing algae and viruses
阐明驱动赤潮藻类与病毒共同进化的分子机制
- 批准号:
23K14265 - 财政年份:2023
- 资助金额:
$ 5.81万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Aqueous Aerosol Chemistry: Elucidating the Mechanisms Causing Mismatch between Field and Laboratory Chemical Composition of Biomass Burning Organic Aerosol
水气溶胶化学:阐明导致生物质燃烧有机气溶胶现场和实验室化学成分不匹配的机制
- 批准号:
2308645 - 财政年份:2023
- 资助金额:
$ 5.81万 - 项目类别:
Standard Grant
Mechanisms causing polarization of the asteroid surface: what are the elementary processes?
引起小行星表面极化的机制:基本过程是什么?
- 批准号:
23K03484 - 财政年份:2023
- 资助金额:
$ 5.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Arrhythmia Mechanisms Modulated by Intercalated Disc Extracellular Nanodomains
闰盘细胞外纳米结构域调节心律失常的机制
- 批准号:
10668025 - 财政年份:2023
- 资助金额:
$ 5.81万 - 项目类别:
Probing the Molecular Mechanisms of Diastolic Dysfunction Using Patient-Specific Stem Cells
利用患者特异性干细胞探讨舒张功能障碍的分子机制
- 批准号:
10739782 - 财政年份:2023
- 资助金额:
$ 5.81万 - 项目类别:
Modeling myosin mechanobiology towards understanding the mechanisms of hypertrophic cardiomyopathy
模拟肌球蛋白力学生物学以了解肥厚型心肌病的机制
- 批准号:
10906499 - 财政年份:2023
- 资助金额:
$ 5.81万 - 项目类别:
Identifying the molecular mechanisms of GEMIN5 mutations in a novel cerebellar ataxia syndrome
鉴定新型小脑共济失调综合征中 GEMIN5 突变的分子机制
- 批准号:
10753403 - 财政年份:2023
- 资助金额:
$ 5.81万 - 项目类别:
Pathogenic Mechanisms of Congenital Disorders of Glycosylation
先天性糖基化障碍的发病机制
- 批准号:
10633548 - 财政年份:2023
- 资助金额:
$ 5.81万 - 项目类别:
A novel genetic mutation reveals the molecular and cellular mechanisms of severe recurrent skin inflammation
一种新的基因突变揭示了严重复发性皮肤炎症的分子和细胞机制
- 批准号:
10679177 - 财政年份:2023
- 资助金额:
$ 5.81万 - 项目类别:
Uncovering mechanisms of CHD2-associated epilepsy using human cortical organoids
利用人类皮质类器官揭示 CHD2 相关癫痫的机制
- 批准号:
10791545 - 财政年份:2023
- 资助金额:
$ 5.81万 - 项目类别: